Phenotypic screens for compounds that target the cellular pathologies underlying Parkinson's disease
Parkinson's disease (PD) is a devastating neurodegenerative disease that affects over one million patients in the US. Yet, no disease modifying drugs exist, only those that temporarily alleviate symptoms. Because of its poorly defined and highly complex disease etiology, it is essential to embr...
Main Authors: | , |
---|---|
Other Authors: | , |
Format: | Article |
Language: | English |
Published: |
Elsevier,
2016-02-25T14:18:16Z.
|
Subjects: | |
Online Access: | Get fulltext |